Rani Therapeutics Hldgs (NASDAQ:RANI) Stock Quotes, Forecast and News Summary

Q: What sector and industry does Rani Therapeutics Hldgs (RANI) operate in?

Rani Therapeutics Hldgs is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

Rani Therapeutics Hldgs Stock (NASDAQ: RANI) stock price, news, charts, stock research, profile.

Open	$1.49
Close	-
Volume / Avg.	76.31K / 536.25K
Day Range	$1.45 - $1.52
52 Wk Range	1.24 - 8.75
Market Cap	$50.44M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	49
Short Interest	7.4%
Days to Cover	2.43

Recent News

Why Rani Therapeutics Shares Are Down 23% Today

Rani Therapeutics shares are trading lower by 23% Tuesday afternoon. The company announced a $10 million direct offering of 3 million shares at $3 per share.

Henry Khederian

Why Ericsson Shares Are Trading Higher By Around 9%; Here Are 20 Stocks Moving Premarket

Avi Kapoor

Why Longboard Pharmaceuticals Shares Are Trading Higher By Around 47%; Here Are 20 Stocks Moving Premarket

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Aug 24

Oct 24

Nov 24

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.2

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$1.49
Close	-
Volume / Avg.	76.31K / 536.25K
Day Range	$1.45 - $1.52
52 Wk Range	1.24 - 8.75
Market Cap	$50.44M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	49
Short Interest	7.4%
Days to Cover	2.43

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Rani Therapeutics Hldgs (RANI) stock?

You can purchase shares of Rani Therapeutics Hldgs (NASDAQ:RANI) through any online brokerage.

View our list of the best stock brokerages

Who are Rani Therapeutics Hldgs (RANI) competitors?

Other companies in Rani Therapeutics Hldgs’s space includes: Cumberland (NASDAQ:CPIX), Iterum Therapeutics (NASDAQ:ITRM), SCYNEXIS (NASDAQ:SCYX), CalciMedica (NASDAQ:CALC) and VYNE Therapeutics (NASDAQ:VYNE).

What is the forecast, or price target, for Rani Therapeutics Hldgs (RANI) stock?

Rani Therapeutics Hldgs has a consensus price target of $12.67.

What is the current price for Rani Therapeutics Hldgs (RANI)?

The stock price for Rani Therapeutics Hldgs (NASDAQ: RANI) is $1.4898 last updated January 24, 2025 at 2:38 PM EST.

Does Rani Therapeutics Hldgs (RANI) pay a dividend?

There are no upcoming dividends for Rani Therapeutics Hldgs.

When is Rani Therapeutics Hldgs (NASDAQ:RANI) reporting earnings?

Rani Therapeutics Hldgs’s Q4 earnings are confirmed for Wednesday, March 19, 2025.

Is Rani Therapeutics Hldgs (RANI) going to split?

There is no upcoming split for Rani Therapeutics Hldgs.

What sector and industry does Rani Therapeutics Hldgs (RANI) operate in?

Rani Therapeutics Hldgs is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

Comments

Rani Therapeutics Hldgs

Rani Therapeutics Hldgs (RANI) Forecast